{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:06:50Z","timestamp":1792598810412,"version":"4.5.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/mnm.0b013e328360d945","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T15:32:59Z","timestamp":1366817579000},"page":"562-570","source":"Crossref","is-referenced-by-count":36,"title":["The relationship between 18F-FDG metabolic volumetric parameters and clinicopathological factors of breast cancer"],"prefix":"10.1097","volume":"34","author":[{"given":"Hayato","family":"Kaida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uhi","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumitsu","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Kage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210212","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.1007\/s00259-004-1529-6","article-title":"Biological characterization of breast cancer by means of PET.","volume":"31","author":"Buck","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-8-20210212","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","article-title":"Progress and promise; highlights of the international expert consensus on the primary therapy of early breast cancer 2007.","volume":"18","author":"Goldhirsch","year":"2007","journal-title":"Ann Oncol"},{"key":"R8-8-20210212","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer; experience from large study with long-term follow up.","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"R12-8-20210212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12149-011-0556-1","article-title":"Usefulness of 18F-FDG uptake with clinicopathologic and immunohistochemical prognostic factors in breast cancer.","volume":"26","author":"Kim","year":"2012","journal-title":"Ann Nucl Med"},{"key":"R16-8-20210212","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/bjs.6459","article-title":"Association between 18F fluorodeoxyglucose uptake and prognostic parameters in breast cancer.","volume":"96","author":"Gil-Rendo","year":"2009","journal-title":"Br J Surg"},{"key":"R19-8-20210212","first-page":"257","article-title":"Evaluation of therapy response in breast and ovarian cancer patients by positron emission tomography (PET).","volume":"45","author":"Baum","year":"2001","journal-title":"Q J Nucl Med"},{"key":"R20-8-20210212","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s10147-010-0120-3","article-title":"Value of PET-FDG in primary breast cancer based on histopathological and immunohistochemical prognostic factors.","volume":"15","author":"Heudel","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"R22-8-20210212","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1471-2407-10-228","article-title":"Use of ERPRHer2 subtypes in conjunction with the 2007 St Gallen consensus statement for early breast cancer.","volume":"10","author":"Bauer","year":"2010","journal-title":"BMC Cancer"},{"key":"R23-8-20210212","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MNM.0b013e328333e3ef","article-title":"Nasopharyngeal carcinoma; relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumor volume and total lesion glycolysis and TNM classification.","volume":"31","author":"Chan","year":"2010","journal-title":"Nucl Med Commun"},{"key":"R26-8-20210212","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/MNM.0b013e328351d4f5","article-title":"Prognostic value of volumetric parameters measured by F-18 FDGCT in surgically resected non-small-cell lung cancer.","volume":"33","author":"Kim","year":"2012","journal-title":"Nucl Med Commun"},{"key":"R30-8-20210212","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ygyno.2012.03.021","article-title":"Metabolic tumor volume by 18F-FDG PETCT is prognostic for stage IVB endometrial carcinoma.","volume":"125","author":"Liu","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R31-8-20210212","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiol.2471070567","article-title":"Bone metastases in patients with metastatic breast cancer; morphologic and metabolic monitoring of response to systemic therapy with integrated PETCT.","volume":"247","author":"Tateishi","year":"2008","journal-title":"Radiology"},{"key":"R32-8-20210212","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2325\/jbcs.12.304","article-title":"Ultrasonographic findings of invasive lobular carcinoma differentiation of invasive lobular carcinoma form invasive ductal carcinoma by ultrasonography.","volume":"12","author":"Ohta","year":"2005","journal-title":"Breast Cancer"},{"key":"R34-8-20210212","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1148\/radiol.12111148","article-title":"Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PETCT in non-small cell lung cancer.","volume":"264","author":"Chen","year":"2012","journal-title":"Radiology"},{"key":"R37-8-20210212","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00259-011-1834-9","article-title":"Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer.","volume":"38","author":"Hatt","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0b013e328360d945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:19:07Z","timestamp":1620962347000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201306000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328360d945","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}